TRU Legionella provides optimized detection of Legionella pneumophila serogroup 1, which is most commonly associated with Legionnaire’s disease.
Meridian Bioscience CEO John Kraeutler said TRU Legionella provides labs with a highly accurate tool that can speed the detection of an under-diagnosed pathogen enabling rapid treatment for the patient.
"TRU Legionella is in distribution, via Meridian Bioscience Europe, for our European customers," Kraeutler added.
